Skip to main content
Erschienen in: Diabetologia 7/2014

01.07.2014 | Article

Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study

verfasst von: Carlos Lorenzo, Anthony J. Hanley, Marian J. Rewers, Steven M. Haffner

Erschienen in: Diabetologia | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Low phosphate and high calcium concentrations have been linked to altered glucose tolerance and reduced insulin sensitivity in non-diabetic individuals. The aim of this study was to examine the relationships of calcium and phosphate levels and the calcium–phosphate product with the development of type 2 diabetes.

Methods

Participants were 863 African-Americans, Hispanics and non-Hispanic whites in the Insulin Resistance Atherosclerosis Study who were free of diabetes at baseline. The mean follow-up period was 5.2 years. The insulin sensitivity index (SI) and acute insulin response (AIR) were directly measured using the frequently sampled IVGTT.

Results

Calcium concentration (OR per 1 SD unit increase, 1.26 [95% CI 1.04, 1.53]) and calcium–phosphate product (OR 1.29 [95% CI 1.04, 1.59]) were associated with incident diabetes after adjustment for demographic variables, family history of diabetes, and 2 h glucose. The relationship between phosphate concentration and progression to diabetes was close to statistical significance (OR 1.21 [95% CI 0.98, 1.49]). Calcium concentration (OR 1.37 [95% CI 1.09, 1.72]) and calcium–phosphate product (OR 1.39 [95% CI 1.09, 1.77]) remained associated with incident diabetes after additional adjustment for BMI, plasma glucose, SI, AIR, C-reactive protein, estimated GFR, diuretic drugs and total calcium intake.

Conclusions/interpretation

Elevated serum calcium and calcium–phosphate product are associated with increased risk of developing type 2 diabetes independently of measured glucose, insulin secretion and insulin resistance. Future studies need to analyse the role of calcium–phosphate homeostasis in the pathophysiology of diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Leiffsson BG, Ahren B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81:2149–2153 Leiffsson BG, Ahren B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81:2149–2153
2.
Zurück zum Zitat Håglin L, Törnkvist B, Bäckman L (2007) Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and -magnesium. Acta Diabetol 44:138–143PubMedCrossRef Håglin L, Törnkvist B, Bäckman L (2007) Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and -magnesium. Acta Diabetol 44:138–143PubMedCrossRef
3.
Zurück zum Zitat Walsh JP, Divitini ML, Knuiman MW (2013) Plasma calcium as a predictor of cardiovascular disease in a community-based cohort. Clin Endocrinol (Oxf) 78:852–857CrossRef Walsh JP, Divitini ML, Knuiman MW (2013) Plasma calcium as a predictor of cardiovascular disease in a community-based cohort. Clin Endocrinol (Oxf) 78:852–857CrossRef
4.
Zurück zum Zitat Jorde R, Schirmer H, Njølstad I et al (2013) Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol 28:569–578PubMedCrossRef Jorde R, Schirmer H, Njølstad I et al (2013) Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol 28:569–578PubMedCrossRef
5.
Zurück zum Zitat Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease: a review. Eur Heart J 25:1776–1787PubMedCrossRef Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease: a review. Eur Heart J 25:1776–1787PubMedCrossRef
6.
Zurück zum Zitat Procopio M, Magro G, Cesario F et al (2002) The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 19:958–961PubMedCrossRef Procopio M, Magro G, Cesario F et al (2002) The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 19:958–961PubMedCrossRef
7.
Zurück zum Zitat Taylor WH, Khaleeli AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17:175–180PubMedCrossRef Taylor WH, Khaleeli AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17:175–180PubMedCrossRef
8.
Zurück zum Zitat Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B (1993) Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95:197–202PubMedCrossRef Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B (1993) Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95:197–202PubMedCrossRef
9.
Zurück zum Zitat Richards ML, Thompson NW (1999) Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery 126:1160–1166PubMedCrossRef Richards ML, Thompson NW (1999) Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery 126:1160–1166PubMedCrossRef
10.
Zurück zum Zitat Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN (1997) Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 46:1171–1177PubMedCrossRef Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN (1997) Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 46:1171–1177PubMedCrossRef
11.
Zurück zum Zitat Sun G, Vasdev S, Martin GR et al (2005) Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 54:3336–3339PubMedCrossRef Sun G, Vasdev S, Martin GR et al (2005) Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 54:3336–3339PubMedCrossRef
12.
Zurück zum Zitat Hagström E, Hellman P, Lundgren E, Lind L, Arnlöv J (2007) Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 50:317–324PubMedCrossRef Hagström E, Hellman P, Lundgren E, Lind L, Arnlöv J (2007) Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 50:317–324PubMedCrossRef
13.
Zurück zum Zitat DeLuca HF (1975) The kidney as an endocrine organ involved in the function of vitamin D. Am J Med 58:39–47PubMedCrossRef DeLuca HF (1975) The kidney as an endocrine organ involved in the function of vitamin D. Am J Med 58:39–47PubMedCrossRef
14.
Zurück zum Zitat National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S77–S84 National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S77–S84
15.
Zurück zum Zitat Block GA, Port FK (2000) Re‐evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendation for a change in management. Am J Kidney Dis 35:1226–1237PubMedCrossRef Block GA, Port FK (2000) Re‐evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendation for a change in management. Am J Kidney Dis 35:1226–1237PubMedCrossRef
16.
Zurück zum Zitat Mills WR, Einstadter D, Finkelhor RS (2004) Relation of calcium-phosphorus product to the severity of aortic stenosis in patients with normal renal function. Am J Cardiol 94:1196–1198PubMedCrossRef Mills WR, Einstadter D, Finkelhor RS (2004) Relation of calcium-phosphorus product to the severity of aortic stenosis in patients with normal renal function. Am J Cardiol 94:1196–1198PubMedCrossRef
17.
Zurück zum Zitat Dhingra R, Sullivan LM, Fox CS et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879–885PubMedCrossRef Dhingra R, Sullivan LM, Fox CS et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879–885PubMedCrossRef
18.
Zurück zum Zitat Tonelli M, Sacks F, Pfeffer M et al (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633PubMedCrossRef Tonelli M, Sacks F, Pfeffer M et al (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633PubMedCrossRef
19.
Zurück zum Zitat Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A (2006) Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 60:734–739PubMedCrossRef Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A (2006) Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 60:734–739PubMedCrossRef
20.
Zurück zum Zitat DeFronzo RA, Lang R (1980) Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl J Med 303:1259–1263PubMedCrossRef DeFronzo RA, Lang R (1980) Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl J Med 303:1259–1263PubMedCrossRef
21.
Zurück zum Zitat Wittmann I, Nagy J (1997) Effectiveness of phosphate supplementation in glucose intolerant, hypophosphatemic patients. Miner Electrolyte Metab 23:62–63PubMed Wittmann I, Nagy J (1997) Effectiveness of phosphate supplementation in glucose intolerant, hypophosphatemic patients. Miner Electrolyte Metab 23:62–63PubMed
22.
Zurück zum Zitat Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study: design, objectives and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study: design, objectives and recruitment results. Ann Epidemiol 5:464–472PubMedCrossRef
23.
Zurück zum Zitat Herbert V, Lau K, Gottlieb C, Bleicher S (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384PubMedCrossRef Herbert V, Lau K, Gottlieb C, Bleicher S (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384PubMedCrossRef
24.
Zurück zum Zitat Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52–58PubMed Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52–58PubMed
25.
Zurück zum Zitat Lott JA, Manning NR, Kyler MK (1989) Proficiency testing in a medical-needs context. Clin Chem 35:347–354PubMed Lott JA, Manning NR, Kyler MK (1989) Proficiency testing in a medical-needs context. Clin Chem 35:347–354PubMed
26.
Zurück zum Zitat Guynn RW, Veloso D, Veech RL (1972) Enzymic determination of inorganic phosphate in the presence of creatine phosphate. Anal Biochem 45:277–285PubMedCrossRef Guynn RW, Veloso D, Veech RL (1972) Enzymic determination of inorganic phosphate in the presence of creatine phosphate. Anal Biochem 45:277–285PubMedCrossRef
27.
28.
Zurück zum Zitat Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMedCrossRef Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMedCrossRef
29.
Zurück zum Zitat Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ (2006) Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 164:449–458PubMedCrossRef Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ (2006) Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 164:449–458PubMedCrossRef
30.
31.
Zurück zum Zitat Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMedCrossRef Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMedCrossRef
32.
Zurück zum Zitat Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029PubMedCentralPubMedCrossRef Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Ko SH, Lee GS, Vo TT (2009) Dietary calcium and 1,25-dihydroxyvitamin D3 regulate transcription of calcium transporter genes in calbindin-D9k knockout mice. J Reprod Dev 55:137–142PubMedCrossRef Ko SH, Lee GS, Vo TT (2009) Dietary calcium and 1,25-dihydroxyvitamin D3 regulate transcription of calcium transporter genes in calbindin-D9k knockout mice. J Reprod Dev 55:137–142PubMedCrossRef
34.
Zurück zum Zitat Resnick LM (1991) Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 14:505–520PubMedCrossRef Resnick LM (1991) Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 14:505–520PubMedCrossRef
35.
Zurück zum Zitat Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297:960–963PubMedCentralPubMedCrossRef Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297:960–963PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Saltevo J, Niskanen L, Kautiainen H et al (2011) Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study. Eur J Endocrinol 165:429–434PubMedCrossRef Saltevo J, Niskanen L, Kautiainen H et al (2011) Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study. Eur J Endocrinol 165:429–434PubMedCrossRef
37.
Zurück zum Zitat Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50:967–973PubMedCrossRef Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50:967–973PubMedCrossRef
38.
Zurück zum Zitat Levy J, Stern Z, Gutman A et al (1986) Plasma calcium and phosphate levels in an adult non-insulin-dependent diabetic population. Calcif Tissue Int 39:316–318PubMedCrossRef Levy J, Stern Z, Gutman A et al (1986) Plasma calcium and phosphate levels in an adult non-insulin-dependent diabetic population. Calcif Tissue Int 39:316–318PubMedCrossRef
39.
Zurück zum Zitat Heath H, Lambert PW, Service FJ et al (1979) Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 49:462–466PubMedCrossRef Heath H, Lambert PW, Service FJ et al (1979) Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 49:462–466PubMedCrossRef
40.
Zurück zum Zitat Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S (2001) Role of apoptosis in pancreatic beta-cell death in diabetes. Diabetes 50(Suppl 1):S44–S447PubMedCrossRef Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S (2001) Role of apoptosis in pancreatic beta-cell death in diabetes. Diabetes 50(Suppl 1):S44–S447PubMedCrossRef
41.
Zurück zum Zitat Wang L, Bhattacharjee A, Zuo Z et al (1999) A low voltage-activated Ca2+ current mediates cytokine-induced pancreatic beta-cell death. Endocrinology 140:1200–1204PubMed Wang L, Bhattacharjee A, Zuo Z et al (1999) A low voltage-activated Ca2+ current mediates cytokine-induced pancreatic beta-cell death. Endocrinology 140:1200–1204PubMed
42.
Zurück zum Zitat Ramadan JW, Steiner SR, O'Neill CM, Nunemaker CS (2011) The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 50:481–490PubMedCentralPubMedCrossRef Ramadan JW, Steiner SR, O'Neill CM, Nunemaker CS (2011) The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 50:481–490PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Zhou YB, Zhang J, Cai Y et al (2012) Insulin resistance induces medial artery calcification in fructose-fed rats. Exp Biol Med (Maywood) 237:50–57CrossRef Zhou YB, Zhang J, Cai Y et al (2012) Insulin resistance induces medial artery calcification in fructose-fed rats. Exp Biol Med (Maywood) 237:50–57CrossRef
44.
Zurück zum Zitat Ljunghall S, Hedstrand H, Hellsing K, Wibell L (1977) Calcium, phosphate and albumin in serum. A population study with special reference to renal stone formers and the prevalence of hyperparathyroidism in middle-aged men. Acta Med Scand 201:23–30PubMedCrossRef Ljunghall S, Hedstrand H, Hellsing K, Wibell L (1977) Calcium, phosphate and albumin in serum. A population study with special reference to renal stone formers and the prevalence of hyperparathyroidism in middle-aged men. Acta Med Scand 201:23–30PubMedCrossRef
45.
Zurück zum Zitat Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Haffner SM (2008) The relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol 3:783–789PubMedCentralPubMedCrossRef Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Haffner SM (2008) The relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol 3:783–789PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336–2341PubMedCrossRef Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336–2341PubMedCrossRef
48.
Zurück zum Zitat Craver L, Marco MP, Martínez I et al (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1–5: achievement of K/DOQI target ranges. Nephrol Dial Transplant 22:1171–1176PubMedCrossRef Craver L, Marco MP, Martínez I et al (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1–5: achievement of K/DOQI target ranges. Nephrol Dial Transplant 22:1171–1176PubMedCrossRef
49.
Zurück zum Zitat Hsu CY, Chertow GM (2002) Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17:1419–1425PubMedCrossRef Hsu CY, Chertow GM (2002) Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17:1419–1425PubMedCrossRef
50.
Zurück zum Zitat Levin A, Bakris GL, Molitch M et al (2006) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38PubMedCrossRef Levin A, Bakris GL, Molitch M et al (2006) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38PubMedCrossRef
Metadaten
Titel
Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study
verfasst von
Carlos Lorenzo
Anthony J. Hanley
Marian J. Rewers
Steven M. Haffner
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 7/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3241-9

Weitere Artikel der Ausgabe 7/2014

Diabetologia 7/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.